Karen S Lynch - Net Worth and Insider Trading
Karen S Lynch Net Worth
The estimated net worth of Karen S Lynch is at least $40 Million dollars as of 2024-12-28. Karen S Lynch is the President and CEO of CVS Health Corp and owns about 431,392 shares of CVS Health Corp (CVS) stock worth over $19 Million. Karen S Lynch is the President of Aetna Inc and owns about 64,261 shares of Aetna Inc (AET) stock worth over $14 Million. Karen S Lynch is also the President, Group Insurance of The Cigna Group and owns about 23,284 shares of The Cigna Group (CI) stock worth over $6 Million. Besides these, Karen S Lynch also holds Magellan Health Inc (MGLN) . Details can be seen in Karen S Lynch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen S Lynch has not made any transactions after 2023-05-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen S Lynch
Karen S Lynch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen S Lynch owns 4 companies in total, including U.S. Bancorp (USB) , CVS Health Corp (CVS) , and Aetna Inc (AET) among others .
Click here to see the complete history of Karen S Lynch’s form 4 insider trades.
Insider Ownership Summary of Karen S Lynch
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
USB | U.S. Bancorp | 2015-12-07 | director |
CVS | CVS Health Corp | 2023-05-03 | EVP & Pres & Aetna Bus Unit |
AET | Aetna Inc | 2018-11-28 | President |
2012-03-05 | President |
Karen S Lynch Latest Holdings Summary
Karen S Lynch currently owns a total of 4 stocks. Among these stocks, Karen S Lynch owns 431,392 shares of CVS Health Corp (CVS) as of May 3, 2023, with a value of $19 Million and a weighting of 48.54%. Karen S Lynch owns 64,261 shares of Aetna Inc (AET) as of September 18, 2017, with a value of $14 Million and a weighting of 34.57%. Karen S Lynch also owns 23,284 shares of The Cigna Group (CI) as of November 16, 2005, with a value of $6 Million and a weighting of 16.41%. The other 1 stocks Magellan Health Inc (MGLN) have a combined weighting of 0.47% among all his current holdings.
Latest Holdings of Karen S Lynch
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CVS | CVS Health Corp | 2023-05-03 | 431,392 | 44.49 | 19,192,630 |
AET | Aetna Inc | 2017-09-18 | 64,261 | 212.70 | 13,668,315 |
CI | The Cigna Group | 2005-11-16 | 23,284 | 278.71 | 6,489,484 |
MGLN | Magellan Health Inc | 2011-09-02 | 1,970 | 94.99 | 187,130 |
Holding Weightings of Karen S Lynch
Karen S Lynch Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen S Lynch has made a total of 1 transactions in CVS Health Corp (CVS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CVS Health Corp is the acquisition of 14,000 shares on May 3, 2023, which cost Karen S Lynch around $976,500.
According to the SEC Form 4 filings, Karen S Lynch has made a total of 0 transactions in Aetna Inc (AET) over the past 5 years. The most-recent trade in Aetna Inc is the sale of 15,271 shares on September 18, 2017, which brought Karen S Lynch around $2 Million.
According to the SEC Form 4 filings, Karen S Lynch has made a total of 0 transactions in The Cigna Group (CI) over the past 5 years. The most-recent trade in The Cigna Group is the sale of 0 shares on November 16, 2005, which brought Karen S Lynch around $0.
More details on Karen S Lynch's insider transactions can be found in the Insider Trading History of Karen S Lynch table.Insider Trading History of Karen S Lynch
- 1
Karen S Lynch Trading Performance
GuruFocus tracks the stock performance after each of Karen S Lynch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karen S Lynch is 12.13%. GuruFocus also compares Karen S Lynch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karen S Lynch within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Karen S Lynch's insider trading performs compared to the benchmark.
Karen S Lynch Ownership Network
Karen S Lynch Owned Company Details
What does U.S. Bancorp do?
Who are the key executives at U.S. Bancorp?
Karen S Lynch is the director of U.S. Bancorp. Other key executives at U.S. Bancorp include Vice Chairman Jodi L Richard , Vice Chairman Shailesh M Kotwal , and EVP & General Counsel & and Sec. James L Chosy .
U.S. Bancorp (USB) Insider Trades Summary
Over the past 18 months, Karen S Lynch made no insider transaction in U.S. Bancorp (USB). Other recent insider transactions involving U.S. Bancorp (USB) include a net sale of 75,339 shares made by Terrance R Dolan , a net sale of 45,000 shares made by Shailesh M Kotwal , and a net sale of 25,916 shares made by Timothy A Welsh .
In summary, during the past 3 months, insiders sold 60,000 shares of U.S. Bancorp (USB) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 286,203 shares of U.S. Bancorp (USB) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 276,203 shares.
U.S. Bancorp (USB)'s detailed insider trading history can be found in Insider Trading Tracker table.
U.S. Bancorp Insider Transactions
Karen S Lynch Mailing Address
Above is the net worth, insider trading, and ownership report for Karen S Lynch. You might contact Karen S Lynch via mailing address: 151 Farmington Avenue, Rw61, Hartford Ct 06156.